by admin | Sep 27, 2019 | Clinical Trials
Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, announced initiation of a Phase 1 open label clinical...
by admin | Sep 27, 2019 | Clinical Trials
Hesperos Inc. announced the University of Central Florida (UCF) and Hesperos have received the first phase of a $3.8 million milestone-based National Institutes of Health (NIH) grant for research involving the company’s human-on-a-chip system. The goal of the research...
by admin | Sep 26, 2019 | Clinical Trials
Mallinckrodt’s treatment made of artificial skin tissue called Stratagraft closed over 80% of second-degree burn wounds in a phase III trial, matching the effectiveness of skin grafts. Mallinckrodt recruited 71 patients with second-degree burns who were eligible...
by admin | Sep 9, 2019 | Clinical Trials
AXON Neuroscience, an industry leading, clinical stage biotech at the forefront of treatment and prevention of Alzheimer’s disease, has announced the results of the Phase II trial for AADvac1, its first-in-class vaccine to slow down the progression of...
by admin | Sep 8, 2019 | Clinical Trials
Orion Biotechnology announced that the Polish National Regulatory Agency and Local Ethics Committee have given approval for the OB-002H-101 Phase 1 safety and acceptability study of OB-002H gel to start screening and enrollment. The OB-002H gel is a topical...